Invesco Ltd. Iovance Biotherapeutics, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 334,257 shares of IOVA stock, worth $564,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares

334,257

Previous 221,928 50.62%

Holding current value

$564,894

Previous $1.64 Million 32.22%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$3.33 - $7.79 $374,055 - $875,042	112,329 Added 50.62%	334,257 $1.11 Million
Q4 2024 Feb 13, 2025	BUY	$7.17 - $12.28 $35,613 - $60,994	4,967 Added 2.29%	221,928 $1.64 Million
Q3 2024 Nov 12, 2024	BUY	$7.28 - $11.9 $21,053 - $34,414	2,892 Added 1.35%	216,961 $2.04 Million
Q2 2024 Aug 13, 2024	SELL	$7.78 - $14.19 $21,231 - $38,724	-2,729 Reduced 1.26%	214,069 $1.72 Million
Q1 2024 May 14, 2024	SELL	$7.59 - $17.47 $4.71 Million - $10.8 Million	-620,360 Reduced 74.1%	216,798 $3.21 Million
Q4 2023 Feb 12, 2024	BUY	$3.3 - $8.89 $2.26 Million - $6.1 Million	686,067 Added 454.08%	837,158 $6.81 Million
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $28,651 - $56,721	6,453 Added 4.46%	151,091 $687,000
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $13,126 - $22,187	2,449 Added 1.72%	144,638 $1.02 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $250,923 - $372,982	45,375 Added 46.87%	142,189 $868,000
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $2,045 - $3,640	-364 Reduced 0.37%	96,814 $618,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $14.7 Million - $20.2 Million	-1,541,077 Reduced 94.07%	97,178 $931,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $146,976 - $422,268	-23,037 Reduced 1.39%	1,638,255 $18.1 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $918,905 - $1.42 Million	74,225 Added 4.68%	1,661,292 $27.7 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $9.27 Million - $15.5 Million	560,410 Added 54.59%	1,587,067 $30.3 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $156,857 - $205,264	-7,708 Reduced 0.75%	1,026,657 $25.3 Million
Q2 2021 Aug 17, 2021	SELL	$16.33 - $33.07 $2.18 Million - $4.42 Million	-133,507 Reduced 11.43%	1,034,365 $26.9 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $12.5 Million - $23 Million	-437,391 Reduced 27.25%	1,167,872 $37 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $769,613 - $1.38 Million	27,447 Added 1.74%	1,605,263 $74.5 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $9.8 Million - $12.8 Million	352,995 Added 28.82%	1,577,816 $51.9 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $28.3 Million - $42.7 Million	1,040,995 Added 566.29%	1,224,821 $33.6 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $1.33 Million - $2.64 Million	67,895 Added 58.57%	183,826 $5.5 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $2.08 Million - $3.41 Million	115,931 New	115,931 $3.21 Million
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $2.4 Million - $3.47 Million	-133,591 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $1.31 Million - $3.28 Million	133,591 New	133,591 $3.28 Million

Others Institutions Holding IOVA

# of Institutions

334

Shares Held

247M

Call Options Held

1.34M

Put Options Held

1.61M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $267M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account